Navigation Links
AccessClosure Signs Distribution Agreement to Enter Into UK, Switzerland and France
Date:5/17/2011

MOUNTAIN VIEW, Calif., May 17, 2011 /PRNewswire/ -- AccessClosure, Inc., the market segment leader in extravascular closure devices, announced today an exclusive agreement with Biosensors International  for the distribution of the Mynx™ Vascular Closure Device throughout the United Kingdom, Switzerland and France. The extravascular Mynx device, designed for patient comfort while providing hemostasis without sutures or implants, will be sold as part of Biosensors' interventional cardiology product range.

"These European countries represent a meaningful market opportunity for us, and we are pleased to be able to partner with Biosensors' established sales force for the distribution of Mynx," said Gregory D. Casciaro, President and CEO of AccessClosure. "Distribution in international markets is a key component of AccessClosure's growth strategy, and provides an excellent complement to our direct sales presence in the United States."

Biosensors will join AccessClosure's existing and growing global network of distributors.  Biosensors is now the fifth largest drug-eluting stent (DES) supplier globally, marketing  its BioMatrix™ family of DES systems which offer the unique combination of Biolimus A9™, an anti-restenotic drug developed by Biosensors exclusively for use with DES, and an abluminally-coated biodegradable polymer. Biosensors has a well established direct presence in the UK, Switzerland and France, and will provide AccessClosure with broad and rapid access to those markets.

"We are pleased to offer the Mynx device as part of our interventional cardiology product range" said Jeffrey B. Jump, CEO of Biosensors. "The Mynx device, paired with our portfolio of drug-eluting and bare-metal stents, allows us to offer a more complete solution to our customers. The Mynx has had great success in the United States and other international markets, and we anticipate similar success in these European countries."

'/>"/>
SOURCE AccessClosure, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
2. AccessClosure Announces Distribution Agreement for Radial Compression Band
3. Governor Daniels Signs Into Law Electronic Tracking Bill
4. Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients
5. Major Medical Diagnostics Manufacturer Signs Agreement to Use AmbiCom Wireless Solution in Its Urinalysis Product Line
6. Digital Assent Signs 100th PatientPad® Customer
7. Sysmex America Signs Distributorship Agreement With LABSCO
8. MedicaMetrix Signs Letter of Intent to Use Vytex® Natural Rubber Latex as Material of Choice in ProstaGlove™
9. Medical Care Technologies Inc. Signs Letter of Intent for Joint Venture in China
10. InstaCare Subsidiary Signs New Agreement for Expanded Management and Sales of Shasta Genstrip Into the $20 Billion Worldwide Diabetes Testing Market
11. More Dangerous Than Drunk Driving, Hope Paige Designs Promotes a THUMBAND for Safe Texting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" research ... http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging of ... orthopedic instrument industry has seen rapid development ... 3.28 billion yuan in 2006 to 9.85 billion yuan ...
(Date:1/15/2014)... 2014  Novation, the leading health care supply chain expertise, ... reseller (VAR) national contracts that expand its portfolio to ... lower costs. These include manufacturer product and service agreements, ... and ongoing IT consulting support. New ...
(Date:1/15/2014)... YORK , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... ... technology, CHICAGO, March 30 ... balloons and stents,to open a completely blocked coronary artery and restore ... attack when performed rapidly.,However, few hospitals can meet the 90-minute treatment ...
... drug appears ... unnecessary, ... improvements in percutaneous coronary,intervention (PCI) for patients with heart attack, among ... unwanted blood clotting. Now a new study has found that high,loading ...
Cached Medicine Technology:Is PCI Safe, Effective After Clot-Busters for Heart Attack? 2Is PCI Safe, Effective After Clot-Busters for Heart Attack? 3BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack 2BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack 3
(Date:4/24/2014)... better understanding of drug interactions, which are a major ... two or more medications are taken at the same ... the other. Similarly, one drug may magnify the ... major cause of illness and hospitalization. However, there ... drug studies in humans. Limits come in part ...
(Date:4/24/2014)... coated with an antimicrobial peptide could help to lower the ... Optometry and Vision Science , official journal of ... is published by Lippincott Williams & Wilkins , a ... animals and now humans support the biocompatibility and safety of ... new research by Debarun Dutta, B.Optom, of The University of ...
(Date:4/24/2014)... will bring together national experts to discuss solutions ... inaugural Brain Health Summit, titled "The Human Brain: ... Dr. Sandra Bond Chapman, founder and chief director ... Grassley (R-IA), U.S. Representative Chaka Fattah (D-PA) and ... Early Learning, U.S. Department of Education. The day ...
(Date:4/24/2014)... End-of-life aspects, the corresponding terminology, and the relevance ... considered in publications on randomized controlled trials (RCTs). ... the German Institute for Quality and Efficiency in ... as final report. , Together with external experts, ... examples: glioblastoma, lung cancer, malignant melanoma, and pancreatic ...
(Date:4/24/2014)... Ill. It is better to give than to receive ... giving, a new study suggests. , The study found that ... as giving their money to family members, are less likely ... from taking risks or keeping the money for themselves. , ... the National Academy of Sciences . , The study focused ...
Breaking Medicine News(10 mins):Health News:Large-scale identification and analysis of suppressive drug interactions 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Study: Altruistic adolescents less likely to become depressed 2
... & Experimental Allergy reveals that there is no association between ... confidence in being able to provide a safe meal to a ... and as much as 8% of children in the UK alone. ... serious being anaphylaxis, which can cause death. Led by Professor Helen ...
... care improves medical outcomes, investigators from the Regenstrief ... providing a call to action for the training ... well as the burgeoning scientific knowledge needed to ... the Patient-Centered Divide: Transforming Health Care Quality Through ...
... Material (SRM) from the National Institute of Standards ... accurately diagnose Huntington,s disease, an inherited degenerative brain ... 50 and progressively leads to physical impairment, dementia ... developed Huntington,s disease has a 50-50 chance of ...
... in French and Spanish . , ... professors Antonio Campos and Miguel Alaminos (histologists), Mara del Mar ... and the ophthalmologist Miguel Gonzlez Andrades, University Hospital San Cecilio, ... Researchers extracted pig corneal cells and replaced them with human ...
... available in French . Montreal, April 13, ... in Tourette syndrome may be as effective as and even ... study published in a special edition of the International Journal ... of the Louis-H. Lafontaine Hospital affiliated with Universit de Montral, ...
... For the first time, scientists at Toronto General Hospital, ... that the Toronto XVIVO System can safely and effectively ... lungs so that they can be successfully transplanted into ... the donor organ pool and improve outcomes after transplantation. ...
Cached Medicine News:Health News:Training future doctors to enlist patients as partners in care 2Health News:New NIST SRM helps improve diagnosis of Huntington's disease 2Health News:Tourette Syndrome: non-drug therapy to reduce tics 2Health News:Toronto XVIV0 Lung Perfusion System allows high-risk lungs to be safely transplanted 2Health News:Toronto XVIV0 Lung Perfusion System allows high-risk lungs to be safely transplanted 3Health News:Toronto XVIV0 Lung Perfusion System allows high-risk lungs to be safely transplanted 4
Oval solid 16 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Cross action serrated handle with polished finish....
Narrow smooth jaws. Serrated handle with polished finish....
Oval solid 24 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 20 mm. Serrated handle with locking thumb screw and polished finish....
Oval solid 16 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Serrated handle with locking thumb screw and polished finish....
Medicine Products: